Category

News

Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

By | Blog, News | No Comments

 Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs

Wayne, PA, June 18, 2019Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today announced  its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trials.…

Register to Participate in the CluePoints Data Quality Challenge

By | Blog, News | No Comments

Take the CluePoints Data Quality Challenge Today!

Are you struggling with how to assess the true value of improving data quality and integrity through Risk-Based Monitoring (RBM)?

Register to participate in the CluePoints Data Quality Challenge to find out first-hand how the ICH E6(R2) has given the industry, not only the a chance to become much more resource efficient while increasing data quality, but to realise huge cost avoidance benefits too.

Announcing the CluePoints Data Quality Challenge

By | Blog, News | No Comments

Are you struggling with how to assess the true value of improving data quality and integrity through Risk-Based Monitoring (RBM)?

Now is your chance to find out first-hand how ICH E6 R2 has given the industry, not only the chance to become much more resource efficient while increasing data quality, but to realise huge cost avoidance benefits too.

The CluePoints & HighPoint Solutions Risk-Based Monitoring Roadshow Recap

By | Blog, News | No Comments

The other week, CluePoints in conjunction with HighPoint Solutions delivered 3 European Roadshows in Basel, Copenhagen and Cambridge, focusing on practical, case-based methods for addressing the challenges of Risk-based Monitoring (RBM). As well as hearing from key opinion leaders in the industry, each event was an ideal forum for attendees to share thoughts and experiences.

Quanticate partners with CluePoints to offer Data Quality Oversight capabilities

By | Blog, News | No Comments

Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the  amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines.

The CluePoints & HighPoint Solutions RBM Roadshow is Coming to a City Near You!

By | Blog, News | No Comments

Since the initial publication of the ICH GCP guidelines, the way clinical trials operate has changed significantly. The ICH E6 (R2) addendum, which came into effect in June 2017,  encourages sponsors to develop a prioritized, risk-based approach to monitoring. However, despite the guidance, some sponsors are still unclear on how to achieve the “gold standard” for monitoring, study execution and oversight.